Skip to main content

Table 2 Direct medical costs for patients with Ischaemic heart disease, Ischaemic and Haemorrhagic stroke and Hypertensive heart disease stratified by resource use for the two study hospitals

From: Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon

 

IHD

n = 92

I-stroke

n = 317

H-stroke

n = 193

HHD

n = 248

Overall

N = 850

Consultation

Mean (SD)

6300 (5200)

13,700 (9800)

10,400 (7300)

7400 (7400)

10,300 (8700)

[11.4 (9.4)]

[24.8 (17.7)]

[18.8 (13.2)]

[13.4 (13.4)]

[18.6 (15.7)]

Median (25th – 75th percentile)

3500 (3500 – 7000)

7000 (7000 – 21,000)

7000 (7000 – 14,000)

7000 (3500 – 7000)

7000 (3500 – 14,000)

[6.3 (6.3–12.7)]

[12.7 (12.7–38.0)]

[12.7 (12.7–25.3)]

[12.7 (6.3–12.7)]

[12.7 (6.3–25.3)]

Sum (% of total costs)

577,500 (0.5)

4,336,500 (1.5)

2,009,000 (1.3)

1,841,000 (1.9)

8,764,000 (1.2)

[1045.4]

[7849.7]

[3636.6]

[3332.5]

[15,864.2]

Laboratory tests

Mean (SD)

96,300 (58,700)

111,000 (74,300)

100,300 (80,900)

102,700 (109,600)

104,500 (86,000)

[174.3 (106.3)]

[200.9 (134.5)]

[181.5 (146.4)]

[185.9 (198.4)]

[189.1 (155.6)]

Median (25th – 75th percentile)

67,700 (63,400–131,300)

103,900 (55,000–144,900)

82,100 (49,700–126,200)

58,300 (20,300 – 150,400)

85,800 (41,100 – 140,800)

[122.5 (114.7–237.7)]

[188.0 (99.5–262.3)]

[148.6 (89.9–228.4)]

[105.5 (36.7–272.2)]

[155.3 (74.4–254.8)]

Sum (% of total costs)

8,856,500 (6.9)

34,646,800 (11.7)

19,258,600 (12.2)

24,742,700 (25.9)

87,504,600 (12.9)

[16,031.6]

[62,715.9]

[34,860.9]

[44,788.0]

[158,396.5]

Imaging & procedures

Mean (SD)

1,072,000 (1,356,000)

193,300 (115,600)

192,000 (317,700)

74,800 (124,900)

262,000 (575,600)

[1940.4 (2454.5)]

[349.9 (209.2)]

[347.5 (575.1)]

[135.4 (226.1)]

[474.2 (1041.9)]

Median (25th – 75th percentile)

675,000 (61,300 – 2,700,000)

176,000 (90,000 – 266,000)

143,100 (75,000 – 200,800)

50,800 (30,000 – 71,300)

125,800 (50,800 – 229,300)

[1221.8 (110.9–4887.4)]

[318.6 (162.9–481.5)]

[259.0 (135.7–363.4)]

[91.9 (54.3–129.1)]

[227.7 (91.9–415.1)]

Sum (% of total costs)

98,623,800 (76.8)

58,582,300 (19.8)

34,941,300 (22.2)

16,374,500 (17.2)

208,521,900 (30.8)

[178,524.0]

[106,042.8]

[63,249.0]

[29,640.3]

[377,456.2]

Medication

Mean (SD)

188,200 (191,900)

332,800 (238,900)

291,100 (221,700)

166,100 (118,500)

258,000 (213,400)

[340.6 (347.3)]

[602.4 (432.4)]

[526.9 (401.3)]

[300.7 (214.5)]

[467.0 (386.3)]

Median (25th – 75th percentile)

127,900 (54,800 – 244,700)

277,300 (150,500 – 447,900)

258,500 (130,300 – 399,600)

136,800 (76,700 – 232,000)

210,600 (103,100 – 349,100)

[231.5 (99.2–442.9)]

[501.9 (272.4–810.7)]

[467.9 (235.8–723.3)]

[247.6 (138.8–419.9)]

[381.2 (186.6–631.9)]

Sum (% of total costs)

17,317,800 (13.5)

103,837,600 (35.1)

51,528,300 (32.7)

41,200,700 (43.2)

213,884,400 (31.6)

[31,347.8]

[187,961.7]

[93,274.0]

[74,579.5]

[387,163.1]

Hospitalization

Mean (SD)

32,400 (48,700)

173,100 (212,500)

240,500 (277,500)

44,900 (61,500)

131,300 (200,900)

[58.6 (88.2)]

[313.3 (384.6)]

[435.3 (502.3)]

[81.3 (111.3)]

[237.7 (363.6)]

Median (25th – 75th percentile)

8000 (4300 – 56,800)

104,100 (42,600 – 261,400)

127,800 (28,400 – 379,400)

26,700 (7000 – 71,000)

56,800 (11,000 – 161,500)

[14.5 (7.8–102.8)]

[188.4 (77.1–473.2)]

[231.3 (51.4–686.7)]

[48.3 (12.6–128.5)]

[102.8 (20.0–292.3)]

Sum (% of total costs)

2,982,100 (2.3)

52,613,900 (17.8)

39,195,000 (24.9)

11,144,400 (11.8)

105,935,400 (15.7)

[5398.0]

[95,239.1]

[70,948.9]

[20,173.0]

[191,759.1]

Physiotherapy

Mean (SD)

578,400 (503,000)

401,500 (368,900)

531,500 (475,900)

 

[1047.0 (910.5)]

[726.8 (667.7)]

 

[962.1 (861.4)]

Median (25th – 75th percentile)

408,500 (152,000 – 988,000)

342,000 (41,300 – 717,300)

389,500 (152,000 – 883,500)

 

[739.4 (275.1–1788.4)]

[619.1 (74.8–1298.4)]

 

[705.0 (275.1–1599.3)]

Sum (% of total costs)

41,645,500 (14.1)

10,438,500 (6.7)

52,084,000 (7.8)

  

[75,384.6]

[18,895.3]

 

[94,280.0]

Total Costs

Mean (SD)

1,395,200 (1,367,000)

932,700 (675,900)

815,400 (705,600)

384,300 (300,500)

796,100 (777,600)

[2525.5 (2474.5)]

[1688.3 (1223.5)]

[1476.0 (1277.2)]

[695.6 (543.9)]

[1441.0 (1407.6)]

Median (25th – 75th percentile)

773,400 (432,100 – 2,940,000)

797,000 (449,700 – 1,258,200)

611,600 (306,400 – 1,117,400)

298,100 (180,400 – 526,600)

571,500 (275,900 – 1,028,100)

[1400.0 (782.2–5321.8)]

[1442.7 (814.0–2277.5)]

[1107.1 (554.6–2022.6)]

[539.6 (328.4–953.2)]

[1034.5 (499.4–1861.0)]

Sum for each CVD and overall

128,357,700

295,662,600

157,370,700

95,303,300

676,694,300

[232,346.8]

[535,194.0]

[284,864.8]

[172,513.4]

[1,224,919.1]

% of total CVD costs combined

19.0

43.7

23.2

14.1

100.0

  1. Costs are in Central African francs (XAF). For ease with comprehension and comparisons, equivalent costs expressed in US dollars are presented in square brackets. CVD Cardiovascular disease, IHD Ischaemic heart disease, I-stroke Ischaemic stroke, H-stroke Haemorrhagic stroke, HHD Hypertensive heart disease, SD Standard deviation